ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 837,68
0,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Day One Biopharmaceuticals Inc (DAWN)

  7. Day One Biopharmaceuticals Inc (DAWN) Actualités

DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DAWN
DateHeureSourceTitreSymboleSociété
30/05/202414h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
29/05/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/05/202400h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
06/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
04/01/202422h06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202315h54Dow Jones NewsDay One Biopharmaceuticals Shares Rally on FDA Priority ReviewNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202313h58Dow Jones NewsDay One Gets FDA Priority Review of Tovorafenib in Pediatric Brain TumorNASDAQ:DAWNDay One Biopharmaceuticals Inc
20/10/202322h01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/09/202323h28Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:DAWNDay One Biopharmaceuticals Inc
27/06/202301h48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAWNDay One Biopharmaceuticals Inc
23/06/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/06/202322h13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/06/202313h00PR Newswire (US)KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMANASDAQ:DAWNDay One Biopharmaceuticals Inc
07/06/202322h58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/06/202322h50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DAWNDay One Biopharmaceuticals Inc
01/05/202315h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322h12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202322h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202300h21Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
09/01/202319h16Dow Jones NewsDay One Biopharma Shares Rise 13% After Positive Topline Results for TovorafenibNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/11/202213h15TipRanksJ.P. Morgan Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/11/202214h55TipRanksJonesTrading Reaffirms Their Buy Rating on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
31/10/202221h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/09/202217h05TipRanksJonesTrading Remains a Buy on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/09/202217h14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/09/202223h15TipRanksDay One Biopharmaceuticals (DAWN) Receives a Buy from JonesTradingNASDAQ:DAWNDay One Biopharmaceuticals Inc
24/06/202201h26TipRanksInsiders Go All-In on These 2 ‘Strong Buy’ StocksNASDAQ:DAWNDay One Biopharmaceuticals Inc
23/06/202214h54TipRanksThis Top Insider Just Increased Its Appetite for DAWN StockNASDAQ:DAWNDay One Biopharmaceuticals Inc
14/06/202223h42TipRanksDay One Stock Is up 139% This Week. How Much Higher Can It Go?NASDAQ:DAWNDay One Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DAWN

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
ML
Michelin
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
EU
PX1
CAC 40
EU
VIV
Vivendi
EU
ORA
Orange
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
EU
BNP
BNP Paribas
NYSE
NKE
Nike
EU
RI
Pernod Ricard
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés